OCM
PRCT icon

Osterweis Capital Management’s Procept Biorobotics PRCT Stock Holding History

Osterweis Capital Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.77M Buy
167,095
+65,770
+65% +$1.65M 0.18% 89
2026
Q1 		$2.53M Sell
101,325
-136,155
-57% -$3.84M 0.13% 89
2025
Q4 		$7.47M Buy
237,480
+3,795
+2% +$126K 0.32% 80
2025
Q3 		$8.34M Buy
233,685
+65,070
+39% +$2.97M 0.38% 71
2025
Q2 		$9.71M Sell
168,615
-5,120
-3% -$289K 0.46% 57
2025
Q1 		$10.1M Buy
173,735
+85,990
+98% +$5.87M 0.5% 59
2024
Q4 		$7.07M Sell
87,745
-48,570
-36% -$4.15M 0.33% 82
2024
Q3 		$10.9M Sell
136,315
-36,030
-21% -$2.56M 0.55% 57
2024
Q2 		$10.5M Buy
172,345
+68,190
+65% +$4.06M 0.54% 52
2024
Q1 		$5.15M Buy
+104,155
New +$4.96M 0.3% 81
2023
Q3 		– Sell
-56,970
Closed -$2.01M – 213
2023
Q2 		$2.01M Sell
56,970
-28,050
-33% -$927K 0.13% 96
2023
Q1 		$2.41M Buy
+85,020
New +$3M 0.16% 97

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Osterweis Capital Management's PRCT Position: Q2 2026 in Review

Osterweis Capital Management increased its Procept Biorobotics (PRCT) stake by 65% in Q2 2026, buying an estimated $1.65M and bringing the position to 167,095 shares worth $3.77M. The position accounts for 0.18% of the portfolio, ranked #89.

Osterweis Capital Management first reported a position in PRCT in Q1 2023 and has held it in 12 quarters since. The position peaked at $10.9M in Q3 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Osterweis Capital Management held 167,095 shares of Procept Biorobotics worth $3.77M as of Q2 2026.
  • Osterweis Capital Management bought 65,770 Procept Biorobotics shares in Q2 2026, an estimated $1.65M.
  • Procept Biorobotics made up 0.18% of Osterweis Capital Management's portfolio in Q2 2026, its #89 holding.
  • Osterweis Capital Management first reported a position in Procept Biorobotics in Q1 2023 and has held it in 12 quarters since.
  • Osterweis Capital Management's Procept Biorobotics position peaked at $10.9M in Q3 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Osterweis Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.